Wanbury

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE107F01022
NSEID: WANBURY
BSEID: 524212

INR

244.45

9.45 (4.02%)

BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 52.99 k

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Cipla

Sun Pharma.Inds.

Torrent Pharma

Fermenta Biotec.

Medicamen Biotec

NGL Fine Chem

Mankind Pharma

Bharat Parenter.

Wanbury

Sudarshan Pharma

Why is Wanbury Ltd ?

High Debt company with Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of 7.05% and Operating profit at 11.65% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at 0 times

With a fall in Net Sales of -17.21%, the company declared Very Negative results in Dec 24

The company has declared negative results for the last 3 consecutive quarters
The company has declared negative results in Jun 24 after 4 consecutive negative quarters
PBT LESS OI(Q) At Rs 0.45 cr has Fallen at -92.4% (vs previous 4Q average)
PAT(Q) At Rs 1.22 cr has Fallen at -82.3% (vs previous 4Q average)
INTEREST(Latest six months) At Rs 20.32 cr has Grown at 35.02%

Stock is technically in a Mildly Bearish range

The technical trend has deteriorated from Mildly Bullish on 09-Apr-25 and has generated 4.02% returns since then
The stocks Bollinger Band and KST technical factors are also Bearish

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Wanbury for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Wanbury

53.65%

0.97

55.41%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.05%

EBIT Growth (5y)

11.65%

EBIT to Interest (avg)

0.86

Debt to EBITDA (avg)

5.36

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

7.52

Tax Ratio

1.10%

Dividend Payout Ratio

Pledged Shares

76.74%

Institutional Holding

0.84%

ROCE (avg)

29.21%

ROE (avg)

17.81%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

19.87

EV to EBIT

18.83

EV to EBITDA

14.88

EV to Capital Employed

4.52

EV to Sales

1.66

PEG Ratio

Dividend Yield

ROCE (Latest)

27.48%

ROE (Latest)

71.23%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-22What is not working for the Company

PBT LESS OI(Q)

At Rs 0.45 cr has Fallen at -92.4% (vs previous 4Q average

PAT(Q)

At Rs 1.22 cr has Fallen at -82.3% (vs previous 4Q average

INTEREST(Latest six months)

At Rs 20.32 cr has Grown at 35.02%

ROCE(HY)

Lowest at 27.92%

OPERATING PROFIT TO INTEREST (Q)

Lowest at 1.37 times

DEBT-EQUITY RATIO(HY)

Highest at 4.66 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.18 times

NET SALES(Q)

At Rs 133.45 cr has Fallen at -7.5% (vs previous 4Q average

Loading Valuation Snapshot...

Here's what is not working for Wanbury

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 0.45 cr has Fallen at -92.4% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 5.91 Cr

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 1.22 cr has Fallen at -82.3% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 6.90 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit to Interest - Quarterly

Lowest at 1.37 times

in the last five quarters

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest - Latest six months

At Rs 20.32 cr has Grown at 35.02%

over previous Half yearly period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Net Sales - Quarterly

At Rs 133.45 cr has Fallen at -7.5% (vs previous 4Q average)

over average Net Sales of the previous four quarters of Rs 144.30 Cr

MOJO Watch

Near term sales trend is negative

Net Sales (Rs Cr)

Debt-Equity Ratio - Half Yearly

Highest at 4.66 times

in the last five half yearly periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly

Lowest at 5.18 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio